Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Ferramenta traduzida da NCCN mede a "temperatura" da saúde mental das pessoas com câncer
  • India - English
  • USA - Pусский
  • USA - English
  • Latin America - español
  • USA - čeština
  • USA - Français
  • USA - Deutsch
  • USA - Polski
  • USA - español
  • USA - slovenčina
  • Middle East - English

O Termômetro da Angústia da NCCN oferece oportunidades para discussão e tratamento da angústia como parte da rotina de cuidado das pessoas com câncer. Esse recurso gratuito foi traduzido para 46 idiomas e está disponível em âmbito mundial.

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

Jul 13, 2020, 07:05 ET

Share this article

Share toX

Share this article

Share toX

PLYMOUTH MEETING, Pensilvânia, 13 de julho de 2020 /PRNewswire/ -- A National Comprehensive Cancer Network® (NCCN®), uma aliança dos principais centros de câncer nos Estados Unidos, anunciou hoje que o Termômetro da Angústia da NCCN (NCCN Distress Thermometer) foi traduzido para 46 idiomas. Esse recurso gratuito ajuda profissionais de saúde de todo o mundo a identificar e abordar os múltiplos aspectos da angústia que os pacientes com câncer podem enfrentar.

Continue Reading
Termômetro da Angústia da NCCN, agora disponível em 46 idiomas em NCCN.org/global.
Termômetro da Angústia da NCCN, agora disponível em 46 idiomas em NCCN.org/global.

A NCCN define "angústia" como uma experiência desagradável de natureza mental, física, social ou espiritual que pode afetar a maneira como as pessoas pensam, sentem ou agem. A angústia pode trazer dificuldades para lidar com o câncer, seus sintomas ou tratamento. Utilizar uma ferramenta como o Termômetro da Angústia da NCCN normaliza e incentiva a discussão sem nenhum estigma que possa fazer com que alguns pacientes evitem falar sobre questões psicológicas ou pessoais profundas. 

"O Termômetro da Angústia da NCCN reconhece que se submeter ao tratamento para o câncer é angustiante para todos. Esse gráfico simples permite que seja mais fácil para os pacientes dizer aos médicos como estão lidando com a situação", explicou o dr. Robert W. Carlson, diretor executivo da NCCN. "Descobrimos que uma pontuação de quatro ou superior é uma indicação para uma avaliação mais detalhada e possível intervenção. O termômetro inclui uma lista de problemas associados para ajudar os profissionais de saúde a estabelecer se a angústia do paciente está relacionada a problemas de ordem prática, familiares, emocionais, espirituais/religiosos, físicos ou a uma combinação deles." 

O Termômetro da Angústia da NCCN foi criado em 1997 por Jimmie C. Holland, pioneira em psico-oncologia. A falecida dra. Holland foi presidente fundadora do Painel das NCCN Guidelines® para Gestão da Angústia e presidente fundadora da Sociedade Americana de Psico-Oncologia. Seu objetivo era fazer com que a discussão sobre a angústia fosse parte da rotina das visitas aos pacientes de oncologia para melhorar o bem-estar físico e psicossocial das pessoas com câncer. 

"Administrar o sofrimento emocional de um paciente, assim como a dor física, é parte essencial do tratamento médico", disse a dra. Sonali Johnson, diretora de informação, defesa de direitos e políticas da União Internacional para Controle do Câncer, a maior organização internacional do mundo de combate ao câncer e que participa também da organização do Dia Mundial do Câncer, 4 de fevereiro. "Os pacientes com câncer são particularmente vulneráveis a ansiedade e depressão, assim como a estresse no trabalho e em casa, e tudo isso pode afetar sua recuperação e qualidade de vida. O Termômetro da Angústia da NCCN oferece aos pacientes e às pessoas que cuidam deles uma ferramenta valiosa para lidar com o impacto psicológico da doença." 

A tradução do Termômetro da Angústia da NCCN é parte dos constantes esforços da Equipe Global da NCCN de aumentar o acesso às Diretrizes da NCCN e dos produtos delas derivados por pessoas que não sejam falantes de inglês. Mais de 100 novas traduções foram publicadas apenas este ano, inclusive diretrizes clínicas e versões mais descomplicadas para pacientes. A NCCN fornece também uma Estrutura para Estratificação de Recursos das Diretrizes da NCCN   (NCCN Framework™) e Diretrizes Harmonizadas (NCCN Harmonized Guidelines™) com recomendações e estratégias pragmáticas para melhorar o tratamento em ambientes com recursos limitados, como países de baixa e média renda. Visite nccn.org/global e participe do debate on-line com o hashtag #NCCNGlobal.

O Termômetro da Angústia da NCCN traduzido pode ser acessado em nccn.org/global/international_adaptations.aspx#distress. As diretrizes para pacientes recentemente atualizadas podem ser acessadas em NCCN Guidelines for Patients®: Distress e em nccn.org/patients.

Sobre a National Comprehensive Cancer Network
A National Comprehensive Cancer Network® (NCCN®) é uma aliança sem fins lucrativos dos principais centros de câncer dedicados ao tratamento de pacientes, pesquisa e educação. A NCCN se dedica a melhorar e promover o tratamento do câncer que seja de alta qualidade, eficaz, eficiente e acessível, para que os pacientes possam viver melhor. As Diretrizes de Prática Clínica da NCNC (NCCN Clinical Practice Guidelines, NCCN Guidelines®) fornecem recomendações transparentes, baseadas em evidências e em consenso de especialistas, para tratamento do câncer, prevenção e serviços de apoio; elas constituem o padrão reconhecido para direção e políticas clínicas em controle do câncer e as diretrizes mais completas e frequentemente atualizadas de prática clínica disponíveis na área da medicina. As diretrizes para os pacientes (NCCN Guidelines for Patients®) fornecem informações de especialistas para tratamento do câncer, para instruir e capacitar pacientes e profissionais de saúde, através do apoio da NCCN Foundation®. A NCCN também promove educação continuada, iniciativas globais, política e colaboração e publicação para pesquisas em oncologia. Visite NCCN.org para obter mais informações e siga a NCCN no Facebook @NCCNorg, Instagram @NCCNorg e Twitter @NCCN.

Contato para a mídia:
Rachel Darwin
267-622-6624
[email protected] 

Foto - https://mma.prnewswire.com/media/1201689/NCCN_DistressThermometer.jpg
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

FONTE National Comprehensive Cancer Network

Related Links

http://www.nccn.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Renuka Iyerová, MD, jmenována novou hlavní lékařskou ředitelkou organizace National Comprehensive Cancer Network (NCCN)

Renuka Iyerová, MD, jmenována novou hlavní lékařskou ředitelkou organizace National Comprehensive Cancer Network (NCCN)

National Comprehensive Cancer Network® (NCCN®) – aliance předních onkologických center, která vydává bezplatná, na důkazech založená a odborným...

Dr Renuka Iyer mianowana nowym dyrektorem medycznym National Comprehensive Cancer Network (NCCN)

Dr Renuka Iyer mianowana nowym dyrektorem medycznym National Comprehensive Cancer Network (NCCN)

National Comprehensive Cancer Network® (NCCN®) - organizacja zrzeszająca czołowe ośrodki onkologiczne, która publikuje bezpłatne, oparte na dowodach...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.